Join us at the IDS 2026 Congress & AISG 2026 Meeting to hear an amazing line up of speakers sharing their knowledge and expertise and learn about the latest advances in diabetes scientific research.
The following speakers have already been confirmed, with many more to be announced soon.
IDS Congress Speakers
2026 Eisenbarth Award and Lecture
Professor Kathryn Haskins
University of Colorado, Anschutz School of Medicine, USA
Professor Kathryn Haskins is a distinguished academic with a strong focus on immunology and molecular biology. Her research spans various areas, including T cell, Cytotoxic T cell, Antigen-presenting cell, and Antigen. Haskins has made significant contributions to the understanding of Type 1 diabetes, Islet, Autoimmunity, and Insulin. Her work often intersects with fields such as NOD mice, CD8, and CD4 T cells. Haskins’ research has been recognized with numerous citations and awards, reflecting her impact on the scientific community.Bottazo Award Lecture
Professor Decio L. Eizirik
Professor at the ULB Center for Diabetes Research, Brussels, Belgium 
Decio L. Eizirik, M.D., Ph.D., is Professor at the ULB center for Diabetes research in Brissles, Beligium and has published >430 full papers and reviews with an h-index of 97. He has received several national and international prizes, including the Juvenile Diabetes Research Foundation (JDRF) Diabetes Care Research Award, 1998, the “2012 Albert Renold Prize Lecture for Outstanding Achievements in Research on the Islets of Langernhans” awarded by the EASD, Berlin, Germany, 10.2012, the “2013 Rumbough Award for outstanding achievements in type 1 diabetes research”, awarded by the JDRF, New York, 12.2013 and the George Eisenbarth Memorial Lecture, awarded by the nPOD, USA, 02.2023. Dr Eizirik has served as Honorary (Scientific) Secretary of the EASD and as Deputy Editor of Diabetologia. His research focus on the mechanisms of pancreatic beta cell dysfunction and death in type 1 diabetes, on the “dialogue” between beta cells and the immune system and on novel approaches to protect beta cells in T1D.
Helen Thomas Memorial Lecture
Professor Chantal Mathieu
Professor of Medicine at the Katholieke Universiteit and Chair of Endocrinology, University Hospital Gasthuisberg Leuven, Belgium
Professor Chantal Mathieu is a physician-scientist who has contributed to the field of diabetes and endocrinology through basic and clinical research. Her basic research work focuses on pathogenesis and prevention of type 1 diabetes. Prof. Mathieu’s clinical work involving new products and treatment paradigms in diabetes, such as new insulins, adjunct therapies and diagnosis of gestational diabetes have made her a speaker in international fora. Prof. Mathieu coordinates the European project ‘INNODIA’ on biomarker discovery and intervention studies in type 1 diabetes. Prof. Mathieu is president of EASD and vice-president of the European Diabetes Forum.